STOCK TITAN

VACCINEX INC (VCNX) Revenue by Year

VCNX

VACCINEX INC generated $601K in revenue in fiscal year 2024. This represents an increase of 5.4% from the prior fiscal year. The table below carries 8 fiscal years, from 2017 to 2024, and the quarters VACCINEX INC has filed alongside them.

FY2024 annual
Revenue $601K
YoY +5.4%
5Y CAGR +2.8%
Source SEC Filings (10-K/10-Q) Latest period FY2024, ended Dec 31, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

VCNX Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Revenue$601K+5.4%$570K+107.3%$275K-69.4%$900K+44.0%$625K+19.5%$523K-27.8%$724K+704.4%$90K

VCNX Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-QQ1'2210-Q
Revenue$213K$52K+160.0%$232K$104K-81.1%N/A$20K-60.0%N/A$550KN/A$50K0.0%N/AN/A

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More VACCINEX INC financials

Frequently Asked Questions

What was VACCINEX INC's revenue in fiscal year 2024?

VACCINEX INC generated $601K in revenue in fiscal year 2024.

How fast is VACCINEX INC's revenue growing?

VACCINEX INC (VCNX) revenue rose by 5.4% year over year, from $570K to $601K in fiscal year 2024.

How has VACCINEX INC's revenue changed over the years?

Across the 8 fiscal years this page covers, VACCINEX INC (VCNX) revenue went from $90K in fiscal year 2017 to $601K in fiscal year 2024.

VACCINEX INC (VCNX) reported $213K in revenue in Q4 2024.

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what VACCINEX INC (VCNX) reported on that line in every period on record.